CYP1B1 and neoplasm: Using as model systems ER-negative breast cancer cells, CAFs from a primary tumor, CAFs from a metastatic site and breast xenografts, we have determined that GPER may be an alternate route toward the regulation of CYP1B1 expression and function by estrogens in different biological targets.